Tuesday, September 4, 2012
Company starting clinical trials of celiac vaccine
Ever since I was diagnosed with celiac disease, I've been hopeful that medical research would lead to some type of vaccine or pharmaceutical treatment.
Of course, we all know the only current treatment is a lifelong gluten-free diet. But I'm even more hopeful today that we're getting closer to a medical treatment that will allow us to eat normally.
I've been following a Boston-area company called ImmusanT which has been working on a vaccine for celiac disease. The company says its product, called Nexvax2 "is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet."
ImmusanT announced today is testing Nexvax2 in clinical trials in Australia and New Zealand. It expects to also launch a clinical trial at four U.S. sites, but it doesn't say where. If it's in Jacksonville sign me up.
This is a development worth following. You can get more information on the company here: